Cargando…

Does multiparametric imaging with (18)F-FDG-PET/MRI capture spatial variation in immunohistochemical cancer biomarkers in head and neck squamous cell carcinoma?

BACKGROUND: The purpose of this study is to test if functional multiparametric imaging with (18)F-FDG-PET/MRI correlates spatially with immunohistochemical biomarker status within a lesion of head and neck squamous cell carcinoma (HNSCC), and also whether a biopsy with the highest FDG uptake was mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasmussen, Jacob H., Olin, Anders, Lelkaitis, Giedrius, Hansen, Adam E., Andersen, Flemming L., Johannesen, Helle H., Kjær, Andreas, Vogelius, Ivan R., Specht, Lena, Bentzen, Søren M., Wessel, Irene, von Buchwald, Christian, Fischer, Barbara M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341803/
https://www.ncbi.nlm.nih.gov/pubmed/32382113
http://dx.doi.org/10.1038/s41416-020-0876-9
_version_ 1783555307379621888
author Rasmussen, Jacob H.
Olin, Anders
Lelkaitis, Giedrius
Hansen, Adam E.
Andersen, Flemming L.
Johannesen, Helle H.
Kjær, Andreas
Vogelius, Ivan R.
Specht, Lena
Bentzen, Søren M.
Wessel, Irene
von Buchwald, Christian
Fischer, Barbara M.
author_facet Rasmussen, Jacob H.
Olin, Anders
Lelkaitis, Giedrius
Hansen, Adam E.
Andersen, Flemming L.
Johannesen, Helle H.
Kjær, Andreas
Vogelius, Ivan R.
Specht, Lena
Bentzen, Søren M.
Wessel, Irene
von Buchwald, Christian
Fischer, Barbara M.
author_sort Rasmussen, Jacob H.
collection PubMed
description BACKGROUND: The purpose of this study is to test if functional multiparametric imaging with (18)F-FDG-PET/MRI correlates spatially with immunohistochemical biomarker status within a lesion of head and neck squamous cell carcinoma (HNSCC), and also whether a biopsy with the highest FDG uptake was more likely to have the highest PD-L1 expression or the highest percentage of vital tumour cells (VTC) compared with a random biopsy. METHODS: Thirty-one patients with HNSCC were scanned on an integrated PET/MRI scanner with FDG prior to surgery in this prospective study. Imaging was quantified with SUV, ADC and K(trans). A 3D-morphometric MRI scan of the specimen was used to co-register the patient and the specimen scans. All specimens were sectioned in consecutive slices, and slices from six different locations were selected randomly from each tumour. Core biopsies were performed to construct TMA blocks for IHC staining with the ten predefined biomarkers. The spatial correlation was assessed with a partial correlation analysis. RESULTS: Twenty-eight patients with a total of 33 lesions were eligible for further analysis. There were significant correlations between the three imaging biomarkers and some of the IHC biomarkers. Moreover, a biopsy taken from the most FDG-avid part of the tumour did not have a statistically significantly higher probability of higher PD-L1 expression or VTC, compared with a random biopsy. CONCLUSION: We found statistically significant correlations between functional imaging parameters and key molecular cancer markers.
format Online
Article
Text
id pubmed-7341803
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-73418032021-05-08 Does multiparametric imaging with (18)F-FDG-PET/MRI capture spatial variation in immunohistochemical cancer biomarkers in head and neck squamous cell carcinoma? Rasmussen, Jacob H. Olin, Anders Lelkaitis, Giedrius Hansen, Adam E. Andersen, Flemming L. Johannesen, Helle H. Kjær, Andreas Vogelius, Ivan R. Specht, Lena Bentzen, Søren M. Wessel, Irene von Buchwald, Christian Fischer, Barbara M. Br J Cancer Article BACKGROUND: The purpose of this study is to test if functional multiparametric imaging with (18)F-FDG-PET/MRI correlates spatially with immunohistochemical biomarker status within a lesion of head and neck squamous cell carcinoma (HNSCC), and also whether a biopsy with the highest FDG uptake was more likely to have the highest PD-L1 expression or the highest percentage of vital tumour cells (VTC) compared with a random biopsy. METHODS: Thirty-one patients with HNSCC were scanned on an integrated PET/MRI scanner with FDG prior to surgery in this prospective study. Imaging was quantified with SUV, ADC and K(trans). A 3D-morphometric MRI scan of the specimen was used to co-register the patient and the specimen scans. All specimens were sectioned in consecutive slices, and slices from six different locations were selected randomly from each tumour. Core biopsies were performed to construct TMA blocks for IHC staining with the ten predefined biomarkers. The spatial correlation was assessed with a partial correlation analysis. RESULTS: Twenty-eight patients with a total of 33 lesions were eligible for further analysis. There were significant correlations between the three imaging biomarkers and some of the IHC biomarkers. Moreover, a biopsy taken from the most FDG-avid part of the tumour did not have a statistically significantly higher probability of higher PD-L1 expression or VTC, compared with a random biopsy. CONCLUSION: We found statistically significant correlations between functional imaging parameters and key molecular cancer markers. Nature Publishing Group UK 2020-05-08 2020-07-07 /pmc/articles/PMC7341803/ /pubmed/32382113 http://dx.doi.org/10.1038/s41416-020-0876-9 Text en © The Author(s), under exclusive licence to Cancer Research UK 2020 https://creativecommons.org/licenses/by/4.0/Note This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).
spellingShingle Article
Rasmussen, Jacob H.
Olin, Anders
Lelkaitis, Giedrius
Hansen, Adam E.
Andersen, Flemming L.
Johannesen, Helle H.
Kjær, Andreas
Vogelius, Ivan R.
Specht, Lena
Bentzen, Søren M.
Wessel, Irene
von Buchwald, Christian
Fischer, Barbara M.
Does multiparametric imaging with (18)F-FDG-PET/MRI capture spatial variation in immunohistochemical cancer biomarkers in head and neck squamous cell carcinoma?
title Does multiparametric imaging with (18)F-FDG-PET/MRI capture spatial variation in immunohistochemical cancer biomarkers in head and neck squamous cell carcinoma?
title_full Does multiparametric imaging with (18)F-FDG-PET/MRI capture spatial variation in immunohistochemical cancer biomarkers in head and neck squamous cell carcinoma?
title_fullStr Does multiparametric imaging with (18)F-FDG-PET/MRI capture spatial variation in immunohistochemical cancer biomarkers in head and neck squamous cell carcinoma?
title_full_unstemmed Does multiparametric imaging with (18)F-FDG-PET/MRI capture spatial variation in immunohistochemical cancer biomarkers in head and neck squamous cell carcinoma?
title_short Does multiparametric imaging with (18)F-FDG-PET/MRI capture spatial variation in immunohistochemical cancer biomarkers in head and neck squamous cell carcinoma?
title_sort does multiparametric imaging with (18)f-fdg-pet/mri capture spatial variation in immunohistochemical cancer biomarkers in head and neck squamous cell carcinoma?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341803/
https://www.ncbi.nlm.nih.gov/pubmed/32382113
http://dx.doi.org/10.1038/s41416-020-0876-9
work_keys_str_mv AT rasmussenjacobh doesmultiparametricimagingwith18ffdgpetmricapturespatialvariationinimmunohistochemicalcancerbiomarkersinheadandnecksquamouscellcarcinoma
AT olinanders doesmultiparametricimagingwith18ffdgpetmricapturespatialvariationinimmunohistochemicalcancerbiomarkersinheadandnecksquamouscellcarcinoma
AT lelkaitisgiedrius doesmultiparametricimagingwith18ffdgpetmricapturespatialvariationinimmunohistochemicalcancerbiomarkersinheadandnecksquamouscellcarcinoma
AT hansenadame doesmultiparametricimagingwith18ffdgpetmricapturespatialvariationinimmunohistochemicalcancerbiomarkersinheadandnecksquamouscellcarcinoma
AT andersenflemmingl doesmultiparametricimagingwith18ffdgpetmricapturespatialvariationinimmunohistochemicalcancerbiomarkersinheadandnecksquamouscellcarcinoma
AT johannesenhelleh doesmultiparametricimagingwith18ffdgpetmricapturespatialvariationinimmunohistochemicalcancerbiomarkersinheadandnecksquamouscellcarcinoma
AT kjærandreas doesmultiparametricimagingwith18ffdgpetmricapturespatialvariationinimmunohistochemicalcancerbiomarkersinheadandnecksquamouscellcarcinoma
AT vogeliusivanr doesmultiparametricimagingwith18ffdgpetmricapturespatialvariationinimmunohistochemicalcancerbiomarkersinheadandnecksquamouscellcarcinoma
AT spechtlena doesmultiparametricimagingwith18ffdgpetmricapturespatialvariationinimmunohistochemicalcancerbiomarkersinheadandnecksquamouscellcarcinoma
AT bentzensørenm doesmultiparametricimagingwith18ffdgpetmricapturespatialvariationinimmunohistochemicalcancerbiomarkersinheadandnecksquamouscellcarcinoma
AT wesselirene doesmultiparametricimagingwith18ffdgpetmricapturespatialvariationinimmunohistochemicalcancerbiomarkersinheadandnecksquamouscellcarcinoma
AT vonbuchwaldchristian doesmultiparametricimagingwith18ffdgpetmricapturespatialvariationinimmunohistochemicalcancerbiomarkersinheadandnecksquamouscellcarcinoma
AT fischerbarbaram doesmultiparametricimagingwith18ffdgpetmricapturespatialvariationinimmunohistochemicalcancerbiomarkersinheadandnecksquamouscellcarcinoma